{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T13:24:26Z","timestamp":1788355466324,"version":"build-2803163510"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T00:00:00Z","timestamp":1770768000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background.<\/jats:title>\n                    <jats:p>Early allograft dysfunction (EAD), defined as hepatic insufficiency within a week of orthotopic liver transplantation (OLT), affects up to 25% of recipients and is associated with morbidity and mortality. Ischemia\u2013reperfusion injury (IRI), the primary driver of EAD, reflects immune and cellular dysregulation triggered by transient tissue oxygen deprivation. Heme oxygenase-1 (HO-1), a cytoprotective enzyme, plays a central role in mitigating hepatic IRI. We hypothesized a distinct perioperative HO-1 signature correlates with EAD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods.<\/jats:title>\n                    <jats:p>We conducted a prospective observational pilot study of 43 primary adult, deceased donor OLT recipients at Emory University Hospital between August 2023 and July 2024. EAD was defined by the Olthoff criteria, using serum bilirubin, international normalized ratio (INR), and aminotransferases. Perioperative arterial serum was assayed preimplantation at anesthesia induction (timepoint, T1), and 2 (T2), and 48\u2009h (T3) postimplantation to measure HO-1 using multiplex immunoassay and compared between recipients with and without EAD. Group comparisons (EAD versus non-EAD) used Mann-Whitney U for continuous variables (reported as medians) and chi-square or Fisher exact test for categorical variables. HO-1 changes over time were assessed with the Friedman test and post hoc comparisons. The Spearman correlation evaluated associations between HO-1 and clinical parameters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.<\/jats:title>\n                    <jats:p>\n                      EAD occurred in 9 of 43 patients (20.9%). Recipients who developed EAD exhibited significantly higher HO-1 levels 2\u2009h postimplantation (T2) (22,665 pg\/mL [interquartile range (IQR): 17 881, 25 361] versus 10,765 pg\/mL [IQR: 8060, 18 903],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0284) and a significantly greater peri-implantation rise in HO-1 levels (T2-T1) (21,050 pg\/mL[IQR: 17 645, 24 765] versus 9,264 pg\/mL [IQR: 6876,17514],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u20050.0358), compared with those without EAD. Receiver operating characteristic curve analysis revealed moderate predictive ability of the peri-implantation rise in HO-1 levels (T2-T1) (area under the curve = 0.7157).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.<\/jats:title>\n                    <jats:p>Peri-implantation HO-1 kinetics may represent a novel biomarker of EAD. Larger validation studies and mechanistic investigations are warranted to refine risk stratification and guide targeted interventions to mitigate EAD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/txd.0000000000001909","type":"journal-article","created":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:00:19Z","timestamp":1770840019000},"page":"e1909","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Heme Oxygenase-1 as a Predictor of Early Allograft Dysfunction in Liver Transplantation: A Prospective Observational Pilot Study"],"prefix":"10.1097","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8105-0928","authenticated-orcid":false,"given":"Elizabeth A.","family":"Wilson","sequence":"first","affiliation":[{"name":"Department of Anesthesiology, Duke University Medical Center, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Rashied","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Bioinformatics, Emory University Rollins School of Public Health, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woodbury","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Barbas","sequence":"additional","affiliation":[{"name":"Division of Abdominal Transplant Surgery, Department of Surgery, Duke University Medical Center, Durham, NC."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig S.","family":"Jabaley","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Emory Critical Care Center, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig M.","family":"Coopersmith","sequence":"additional","affiliation":[{"name":"Department of Surgery, Emory Critical Care Center, Emory University School of Medicine, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, Emory University School of Medicine, Children\u2019s Healthcare of Atlanta, Atlanta, GA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"OXIDATIVE Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,2,11]]},"reference":[{"key":"R1-20260211","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/lt.22091","article-title":"Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors.","volume":"16","author":"Olthoff","year":"2010","journal-title":"Liver Transpl"},{"issue":"Suppl 2","key":"R2-20260211","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1002\/lt.23746","article-title":"Early allograft dysfunction: causes, recognition, and management.","volume":"19","author":"Deschenes","year":"2013","journal-title":"Liver Transpl"},{"key":"R3-20260211","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/ajt.13527","article-title":"Early allograft dysfunction after liver transplantation is associated with short- and long-term kidney function impairment.","volume":"16","author":"Wadei","year":"2016","journal-title":"Am J Transplant"},{"key":"R4-20260211","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.hbpd.2019.02.005","article-title":"Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction.","volume":"18","author":"Bastos-Neves","year":"2019","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R5-20260211","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/liv.14091","article-title":"Ischaemia reperfusion injury in liver transplantation: cellular and molecular mechanisms.","volume":"39","author":"Dar","year":"2019","journal-title":"Liver Int"},{"key":"R6-20260211","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7555\/JBR.32.20180087","article-title":"Hepatic ischemia-reperfusion injury in liver transplant setting: mechanisms and protective strategies.","volume":"33","author":"Rampes","year":"2019","journal-title":"J Biomed Res"},{"key":"R7-20260211","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1213\/ANE.0000000000006902","article-title":"Intraoperative anesthetic strategies to mitigate early allograft dysfunction after orthotopic liver transplantation: a narrative review.","volume":"139","author":"Wilson","year":"2024","journal-title":"Anesth Analg"},{"key":"R8-20260211","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1111\/ajt.13145","article-title":"Genomic profiles and predictors of early allograft dysfunction after human liver transplantation.","volume":"15","author":"Kurian","year":"2015","journal-title":"Am J Transplant"},{"key":"R9-20260211","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/j.1600-6143.2011.03587.x","article-title":"Major challenges limiting liver transplantation in the United States.","volume":"11","author":"Wertheim","year":"2011","journal-title":"Am J Transplant"},{"key":"R10-20260211","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1111\/j.1600-6143.2007.01758.x","article-title":"Waitlist mortality decreases with increased use of extended criteria donor liver grafts at adult liver transplant centers.","volume":"7","author":"Barshes","year":"2007","journal-title":"Am J Transplant"},{"key":"R11-20260211","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.jhep.2013.07.016","article-title":"KEAP1-NRF2 complex in ischemia-induced hepatocellular damage of mouse liver transplants.","volume":"59","author":"Ke","year":"2013","journal-title":"J Hepatol"},{"key":"R12-20260211","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jhep.2011.05.023","article-title":"HO-1-STAT3 axis in mouse liver ischemia\/reperfusion injury: regulation of TLR4 innate responses through PI3K\/PTEN signaling.","volume":"56","author":"Ke","year":"2012","journal-title":"J Hepatol"},{"key":"R13-20260211","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.freeradbiomed.2020.02.012","article-title":"Heme Oxygenase-1 in liver transplant ischemia-reperfusion injury: from bench-to-bedside.","volume":"157","author":"Hirao","year":"2020","journal-title":"Free Radic Biol Med"},{"key":"R14-20260211","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1152\/physrev.00023.2017","article-title":"The KEAP1-NRF2 system: a thiol-based sensor-effector apparatus for maintaining redox homeostasis.","volume":"98","author":"Yamamoto","year":"2018","journal-title":"Physiol Rev"},{"key":"R15-20260211","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.bbrc.2019.11.053","article-title":"Hepatocellular HO-1 mediated iNOS-induced hepatoprotection against liver ischemia reperfusion injury.","volume":"521","author":"Qiao","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"R16-20260211","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/hep.32184","article-title":"Macrophage nuclear factor erythroid 2-related factor 2 deficiency promotes innate immune activation by tissue inhibitor of metalloproteinase 3-mediated RhoA\/ROCK pathway in the ischemic liver.","volume":"75","author":"Rao","year":"2022","journal-title":"Hepatology"},{"key":"R17-20260211","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/ajt.12954","article-title":"ATF3-mediated NRF2\/HO-1 signaling regulates TLR4 innate immune responses in mouse liver ischemia\/reperfusion injury.","volume":"15","author":"Rao","year":"2015","journal-title":"Am J Transplant"},{"key":"R18-20260211","doi-asserted-by":"crossref","first-page":"e0301281","DOI":"10.1371\/journal.pone.0301281","article-title":"OXIDATIVE study: a pilot prospective observational cohort study protocol examining the influence of peri-reperfusion hyperoxemia and immune dysregulation on early allograft dysfunction after orthotopic liver transplantation.","volume":"19","author":"Wilson","year":"2024","journal-title":"PLoS One"},{"key":"R19-20260211","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1002\/hep.26100","article-title":"beta-catenin regulates innate and adaptive immunity in mouse liver ischemia-reperfusion injury.","volume":"57","author":"Ke","year":"2013","journal-title":"Hepatology"},{"key":"R20-20260211","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/lt.22451","article-title":"Serum cytokine profiles associated with early allograft dysfunction in patients undergoing liver transplantation.","volume":"18","author":"Friedman","year":"2012","journal-title":"Liver Transpl"},{"key":"R21-20260211","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1160\/TH09-11-0802","article-title":"Plasma haemoxygenase-1 in coronary artery disease. a comparison with angiogenin, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1 and vascular endothelial growth factor.","volume":"104","author":"Idriss","year":"2010","journal-title":"Thromb Haemost"},{"key":"R22-20260211","doi-asserted-by":"crossref","first-page":"6138124","DOI":"10.1155\/2018\/6138124","article-title":"Plasma heme oxygenase-1 levels in patients with coronary and peripheral artery diseases.","volume":"2018","author":"Kishimoto","year":"2018","journal-title":"Dis Markers"},{"key":"R23-20260211","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/15353702221139185","article-title":"Association of heme-oxygenase 1, hemopexin, and heme levels with markers of disease severity in COVID-19.","volume":"248","author":"de Lima","year":"2023","journal-title":"Exp Biol Med (Maywood)"},{"key":"R24-20260211","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SHK.0b013e3181e14de9","article-title":"Heme oxygenase 1 polymorphisms and plasma concentrations in critically ill patients.","volume":"34","author":"Saukkonen","year":"2010","journal-title":"Shock"},{"key":"R25-20260211","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/cells10030515","article-title":"Heme oxgenase-1, a cardinal modulator of regulated cell death and inflammation.","volume":"10","author":"Ryter","year":"2021","journal-title":"Cells"},{"key":"R26-20260211","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/152308602760598891","article-title":"Heme oxygenase-1: redox regulation and role in the hepatic response to oxidative stress.","volume":"4","author":"Bauer","year":"2002","journal-title":"Antioxid Redox Signal"},{"key":"R27-20260211","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1007\/s10571-023-01388-8","article-title":"The mechanisms of ferroptosis under hypoxia.","volume":"43","author":"Gao","year":"2023","journal-title":"Cell Mol Neurobiol"},{"key":"R28-20260211","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1053\/jhep.2001.21161","article-title":"Altered expression of heme oxygenase-1 in the livers of patients with portal hypertensive diseases.","volume":"33","author":"Makino","year":"2001","journal-title":"Hepatology"},{"key":"R29-20260211","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jhep.2004.11.040","article-title":"Heme oxygenase-1 levels and oxidative stress-related parameters in non-alcoholic fatty liver disease patients.","volume":"42","author":"Malaguarnera","year":"2005","journal-title":"J Hepatol"},{"key":"R30-20260211","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1001\/jamasurg.2017.5040","article-title":"Evaluation of early allograft function using the liver graft assessment following transplantation risk score model.","volume":"153","author":"Agopian","year":"2018","journal-title":"JAMA Surg"},{"key":"R31-20260211","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.transproceed.2022.02.045","article-title":"Early postoperative transaminase activities affecting early and late liver graft survival.","volume":"54","author":"Figiel","year":"2022","journal-title":"Transplant Proc"},{"key":"R32-20260211","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/tri.12723","article-title":"High serum aspartate transaminase levels on day 3 postliver transplantation correlates with graft and patient survival and would be a valid surrogate for outcome in liver transplantation clinical trials.","volume":"29","author":"Robertson","year":"2016","journal-title":"Transpl Int"},{"key":"R33-20260211","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/00007890-199801150-00013","article-title":"Significance of early aminotransferase elevation after liver transplantation.","volume":"65","author":"Rosen","year":"1998","journal-title":"Transplantation"},{"key":"R34-20260211","first-page":"101615","article-title":"Clinical importance of serum heme oxygenase-1 measurement in patients with acute exacerbation of idiopathic pulmonary fibrosis triggered by coronavirus disease 2019.","volume":"36","author":"Hara","year":"2022","journal-title":"Respir Med Case Rep"},{"key":"R35-20260211","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s12890-020-01341-1","article-title":"Serum heme oxygenase-1 measurement is useful for evaluating disease activity and outcomes in patients with acute respiratory distress syndrome and acute exacerbation of interstitial lung disease.","volume":"20","author":"Nagasawa","year":"2020","journal-title":"BMC Pulm Med"},{"key":"R36-20260211","first-page":"9627420","article-title":"ELISA development for serum hemeoxygenase-1 and its application to patients with acute respiratory distress syndrome.","volume":"2018","author":"Hara","year":"2018","journal-title":"Can Respir J"},{"key":"R37-20260211","doi-asserted-by":"crossref","first-page":"e0273500","DOI":"10.1371\/journal.pone.0273500","article-title":"Heme oxygenase-1 as an important predictor of the severity of COVID-19.","volume":"17","author":"Hara","year":"2022","journal-title":"PLoS One"},{"key":"R38-20260211","doi-asserted-by":"crossref","first-page":"108953","DOI":"10.1016\/j.steroids.2021.108953","article-title":"Acute serum protein and cytokine response of single dose of prednisone in adult volunteers.","volume":"178","author":"Roy","year":"2022","journal-title":"Steroids"},{"key":"R39-20260211","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0165-5728(96)00206-8","article-title":"Comparison of the effects of oral versus intravenous methylprednisolone regimens on peripheral blood T lymphocyte adhesion molecule expression, T cell subsets distribution and TNF alpha concentrations in multiple sclerosis.","volume":"74","author":"Pitzalis","year":"1997","journal-title":"J Neuroimmunol"},{"key":"R40-20260211","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.bbrc.2007.04.136","article-title":"Corticosteroid enhances heme oxygenase-1 production by circulating monocytes by up-regulating hemoglobin scavenger receptor and amplifying the receptor-mediated uptake of hemoglobin-haptoglobin complex.","volume":"358","author":"Yamazaki","year":"2007","journal-title":"Biochem Biophys Res Commun"},{"key":"R41-20260211","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1182\/blood-2010-04-277319","article-title":"Glucocorticoid treatment skews human monocyte differentiation into a hemoglobin-clearance phenotype with enhanced heme-iron recycling and antioxidant capacity.","volume":"116","author":"Vallelian","year":"2010","journal-title":"Blood"},{"issue":"Pt 3Pt 3","key":"R42-20260211","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1042\/bj2790891","article-title":"Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. feedback regulation by glucocorticoids.","volume":"279 (Pt 3)","author":"Cantoni","year":"1991","journal-title":"Biochem J"},{"key":"R43-20260211","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s43440-019-00055-4","article-title":"Mycophenolate mofetil attenuates concanavalin a-induced acute liver injury through modulation of TLR4\/NF-kappaB and Nrf2\/HO-1 pathways.","volume":"72","author":"Serrya","year":"2020","journal-title":"Pharmacol Rep"},{"key":"R44-20260211","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.niox.2011.01.002","article-title":"Tacrolimus modulates liver and pancreas nitric oxide synthetase and heme-oxygenase isoforms and cytokine production after endotoxemia.","volume":"24","author":"Balibrea","year":"2011","journal-title":"Nitric Oxide"},{"key":"R45-20260211","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.transproceed.2007.01.035","article-title":"A role for HO-1 in renal function impairment in animals subjected to ischemic and reperfusion injury and treated with immunosuppressive drugs.","volume":"39","author":"Feitoza","year":"2007","journal-title":"Transplant Proc"},{"key":"R46-20260211","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1139\/cjpp-2020-0547","article-title":"Protective effects of selenium in tacrolimus-induced lung toxicity: potential role of heme oxygenase 1.","volume":"99","author":"Ibrahim","year":"2021","journal-title":"Can J Physiol Pharmacol"}],"container-title":["Transplantation Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:00:23Z","timestamp":1770840023000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TXD.0000000000001909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,11]]},"references-count":46,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/txd.0000000000001909","relation":{},"ISSN":["2373-8731"],"issn-type":[{"value":"2373-8731","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,11]]}}}